Advanced search
Publication Cover
Pharmacogenomics Volume 10, 2009 - Issue 11
Submit an article Journal homepage
493
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Presence of CYP2C9*3 Allele Increases Risk for Hypoglycemia in Type 2 Diabetic Patients Treated with Sulfonylureas

Georgia Ragia1 Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100Alexandroupolis, Greece.
,
Ioannis Petridis1 Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100Alexandroupolis, Greece. ;2 Academic General Hospital of Alexandroupolis, Thrace, Greece
,
Anna Tavridou1 Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100Alexandroupolis, Greece.
,
Dimitrios Christakidis2 Academic General Hospital of Alexandroupolis, Thrace, Greece
&
Vangelis G Manolopoulos1 Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100Alexandroupolis, Greece. Correspondence[email protected]
Pages 1781-1787 | Published online: 05 Nov 2009

Bibliography

  • Amiel SA , DixonT, MannR, JamesonK: Hypoglycaemia in Type 2 diabetes.Diabet. Med.25 , 245–254 (2008).
  • Murata GH , DuckworthWC, HoffmanRM et al.: Hypoglycemia in Type 2 diabetes: a critical review.Biomed. Pharmacother.58 , 551–559 (2004).
  • Rendell M : The role of sulphonylureas in the management of Type 2 diabetes mellitus.Drugs64 , 1339–1358 (2004).
  • Burge MR , Schmitz-FiorentinoK, FischetteC, QuallsCR, SchadeDS: A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in Type 2 diabetes mellitus.JAMA279 , 137–143 (1998).
  • Salas M , CaroJJ: Are hypoglycaemia and other adverse effects similar among sulphonylureas?Adverse Drug React. Toxicol. Rev.21 , 205–217 (2002).
  • Holstein A , EgbertsEH: Risk of hypoglycaemia with oral antidiabetic agents in patients with type 2 diabetes.Exp. Clin. Endocrinol. Diabetes111 , 405–414 (2003).
  • Kirchheiner J , RootsI, GoldammerM, RosenkranzB, BrockmollerJ: Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.Clin. Pharmacokinet.44 , 1209–1225 (2005).
  • Becker ML , VisserLE, TrienekensPH et al.: Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in Type II diabetes mellitus.Clin. Pharmacol. Ther.83 , 288–292 (2008).
  • Suzuki K , YanagawaT, ShibasakiT et al.: Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with Type 2 diabetes.Diabetes Res. Clin. Pract.72 , 148–154 (2006).
  • Niemi M , CascorbiI, TimmR et al.: Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes.Clin. Pharmacol. Ther.72 , 326–332 (2002).
  • Wang R , ChenK, WenSY, LiJ, WangSQ: Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms.Clin. Pharmacol. Ther.78 , 90–92 (2005).
  • Yin OQ , TomlinsonB, ChowMS: CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects.Clin. Pharmacol. Ther.78 , 370–377 (2005).
  • Zhang Y , SiD, ChenX et al.: Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects.Br. J. Clin. Pharmacol.64 , 67–74 (2007).
  • Manolopoulos VG : Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Clin. Chem. Lab. Med.45 , 801–814 (2007).
  • Arvanitidis K , RagiaG, IordanidouM et al.: Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.Fundam. Clin. Pharmacol.21 , 419–426 (2007).
  • Xie HG , PrasadHC, KimRB, SteinCM: CYP2C9 allelic variants: ethnic distribution and functional significance.Adv. Drug Deliv. Rev.54 , 1257–1270 (2002).
  • Kirchheiner J , BauerS, MeinekeI et al.: Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers.Pharmacogenetics12 , 101–109 (2002).
  • Holstein A , PlaschkeA, PtakM et al.: Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.Br. J. Clin. Pharmacol.60 , 103–106 (2005).
  • Ragia G , ArvanitidisKI, TavridouA, ManolopoulosVG: Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.Pharmacogenomics10 , 43–49 (2009).
  • American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care28 , 1245–1249 (2005).
  • Scheen AJ : Drug interactions of clinical importance with antihyperglycaemic agents: an update.Drug Saf.28 , 601–631 (2005).
  • Kim YM , YooSH, KangRY et al.: Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.Am. J. Health Syst. Pharm.64 , 166–175 (2007).
  • Siguret V , PautasE, Gouin-ThibaultI: Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.Vitam. Horm.78 , 247–264 (2008).
  • Elbekai RH , El-KadiAO: Cytochrome P450 enzymes: central players in cardiovascular health and disease.Pharmacol. Ther.112 , 564–587 (2006).
  • Yu BN , LuoCH, WangD et al.: CYP2C9 allele variants in Chinese hypertension patients and healthy controls.Clin. Chim. Acta348 , 57–61 (2004).

▪ Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.